These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28906003)

  • 61. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein.
    Rodon J; Okba NMA; Te N; van Dieren B; Bosch BJ; Bensaid A; Segalés J; Haagmans BL; Vergara-Alert J
    Emerg Microbes Infect; 2019; 8(1):1593-1603. PubMed ID: 31711379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.
    Volz A; Kupke A; Song F; Jany S; Fux R; Shams-Eldin H; Schmidt J; Becker C; Eickmann M; Becker S; Sutter G
    J Virol; 2015 Aug; 89(16):8651-6. PubMed ID: 26018172
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of Fc Fusion on Folding and Immunogenicity of Middle East Respiratory Syndrome Coronavirus Spike Protein.
    Chun J; Cho Y; Park KH; Choi H; Cho H; Lee HJ; Jang H; Kim KH; Oh YK; Kim YB
    J Microbiol Biotechnol; 2019 May; 29(5):813-819. PubMed ID: 30982320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice.
    Kim E; Okada K; Kenniston T; Raj VS; AlHajri MM; Farag EA; AlHajri F; Osterhaus AD; Haagmans BL; Gambotto A
    Vaccine; 2014 Oct; 32(45):5975-82. PubMed ID: 25192975
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Novel Bacterium-Like Particle Vaccine Displaying the MERS-CoV Receptor-Binding Domain Induces Specific Mucosal and Systemic Immune Responses in Mice.
    Li E; Chi H; Huang P; Yan F; Zhang Y; Liu C; Wang Z; Li G; Zhang S; Mo R; Jin H; Wang H; Feng N; Wang J; Bi Y; Wang T; Sun W; Gao Y; Zhao Y; Yang S; Xia X
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31470645
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description.
    Al-Abdallat MM; Payne DC; Alqasrawi S; Rha B; Tohme RA; Abedi GR; Al Nsour M; Iblan I; Jarour N; Farag NH; Haddadin A; Al-Sanouri T; Tamin A; Harcourt JL; Kuhar DT; Swerdlow DL; Erdman DD; Pallansch MA; Haynes LM; Gerber SI;
    Clin Infect Dis; 2014 Nov; 59(9):1225-33. PubMed ID: 24829216
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessing the Detection of Middle East Respiratory Syndrome Coronavirus IgG in Suspected and Proven Cases of Middle East Respiratory Syndrome Coronavirus Infection.
    Alhetheel A; Altalhi H; Albarrag A; Shakoor Z; Mohamed D; El-Hazmi M; Somily A; Barry M; Bakhrebah M; Nassar M
    Viral Immunol; 2017 Nov; 30(9):649-653. PubMed ID: 28873020
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
    Folegatti PM; Bittaye M; Flaxman A; Lopez FR; Bellamy D; Kupke A; Mair C; Makinson R; Sheridan J; Rohde C; Halwe S; Jeong Y; Park YS; Kim JO; Song M; Boyd A; Tran N; Silman D; Poulton I; Datoo M; Marshall J; Themistocleous Y; Lawrie A; Roberts R; Berrie E; Becker S; Lambe T; Hill A; Ewer K; Gilbert S
    Lancet Infect Dis; 2020 Jul; 20(7):816-826. PubMed ID: 32325038
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020.
    Perera RA; Mok CK; Tsang OT; Lv H; Ko RL; Wu NC; Yuan M; Leung WS; Chan JM; Chik TS; Choi CY; Leung K; Chan KH; Chan KC; Li KC; Wu JT; Wilson IA; Monto AS; Poon LL; Peiris M
    Euro Surveill; 2020 Apr; 25(16):. PubMed ID: 32347204
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stabilized coronavirus spike stem elicits a broadly protective antibody.
    Hsieh CL; Werner AP; Leist SR; Stevens LJ; Falconer E; Goldsmith JA; Chou CW; Abiona OM; West A; Westendorf K; Muthuraman K; Fritch EJ; Dinnon KH; Schäfer A; Denison MR; Chappell JD; Baric RS; Graham BS; Corbett KS; McLellan JS
    Cell Rep; 2021 Nov; 37(5):109929. PubMed ID: 34710354
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MERS-CoV Antibodies in Humans, Africa, 2013-2014.
    Liljander A; Meyer B; Jores J; Müller MA; Lattwein E; Njeru I; Bett B; Drosten C; Corman VM
    Emerg Infect Dis; 2016 Jun; 22(6):1086-9. PubMed ID: 27071076
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach.
    van Tol S; Mögling R; Li W; Godeke GJ; Swart A; Bergmans B; Brandenburg A; Kremer K; Murk JL; van Beek J; Wintermans B; Reimerink J; Bosch BJ; Reusken C
    Emerg Microbes Infect; 2020 Dec; 9(1):1965-1973. PubMed ID: 32819220
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development and comparison of enzyme-linked immunosorbent assays based on recombinant trimeric full-length and truncated spike proteins for detecting antibodies against porcine epidemic diarrhea virus.
    Chang CY; Peng JY; Cheng YH; Chang YC; Wu YT; Tsai PS; Chiou HY; Jeng CR; Chang HW
    BMC Vet Res; 2019 Nov; 15(1):421. PubMed ID: 31775769
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells.
    Kato T; Takami Y; Kumar Deo V; Park EY
    J Biotechnol; 2019 Dec; 306():177-184. PubMed ID: 31614169
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Potential of Developing Pan-Coronaviral Antibodies to Spike Peptides in Convalescent COVID-19 Patients.
    Rabets A; Bila G; Grytsko R; Samborskyy M; Rebets Y; Vari SG; Pagneux Q; Barras A; Boukherroub R; Szunerits S; Bilyy R
    Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):5. PubMed ID: 33677719
    [TBL] [Abstract][Full Text] [Related]  

  • 76. DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.
    Chi H; Zheng X; Wang X; Wang C; Wang H; Gai W; Perlman S; Yang S; Zhao J; Xia X
    Vaccine; 2017 Apr; 35(16):2069-2075. PubMed ID: 28314561
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future.
    Al-Tawfiq JA; Memish ZA
    Travel Med Infect Dis; 2020; 37():101785. PubMed ID: 32534208
    [No Abstract]   [Full Text] [Related]  

  • 78. Detection of MERS-CoV antigen on formalin-fixed paraffin-embedded nasal tissue of alpacas by immunohistochemistry using human monoclonal antibodies directed against different epitopes of the spike protein.
    Haverkamp AK; Bosch BJ; Spitzbarth I; Lehmbecker A; Te N; Bensaid A; Segalés J; Baumgärtner W
    Vet Immunol Immunopathol; 2019 Dec; 218():109939. PubMed ID: 31526954
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience.
    Ko JH; Seok H; Cho SY; Ha YE; Baek JY; Kim SH; Kim YJ; Park JK; Chung CR; Kang ES; Cho D; Müller MA; Drosten C; Kang CI; Chung DR; Song JH; Peck KR
    Antivir Ther; 2018; 23(7):617-622. PubMed ID: 29923831
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of an antibody-dependent cellular cytotoxicity reporter assay for measuring anti-Middle East Respiratory Syndrome antibody bioactivity.
    Cao J; Wang L; Yu C; Wang K; Wang W; Yan J; Li Y; Yang Y; Wang X; Wang J
    Sci Rep; 2020 Oct; 10(1):16615. PubMed ID: 33024203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.